Vulnerability Management & Patch Compliance Posture

NovaCrest Pharmaceuticals — 90-Day Security Posture Analysis

Exploitable Criticals (External)
23
▲ 4 vs. last week
RAVES Score
687
▼ 111 (90d)
SLA Compliance
89.2%
▼ 3.8% vs. target
Mean Time to Patch
11.4d
▼ 2.1d (90d)
Scan Coverage
97.3%
▲ 1.2% (90d)
Reopen Rate
3.8%
Within threshold
EPSS × CVSS Risk Matrix — Critical & High Vulnerabilities
RAVES Score Trend (90 Days)
Patch SLA Compliance by Team
Vuln Age (Criticals)
MTTP by Severity
Weekly New Criticals
Top Critical Vulnerabilities — Open & Exploitable
CVE ID CVSS EPSS Asset Team Age (Days) Status
CVE-2024-45779.80.87web-prod-12.novacrest.comPlatform Eng8Patching
CVE-2024-309410.00.94erp-gateway-03.novacrest.comERP Team19Delayed
CVE-2024-214139.60.76mail-relay-02.novacrest.comInfra Ops12Patching
CVE-2024-261699.80.71vpn-gateway-01.novacrest.comNetSec6Testing
CVE-2024-10869.10.82api-prod-07.novacrest.comPlatform Eng14Patching
CVE-2024-271988.80.68jenkins-master.novacrest.comDevOps21Delayed
CVE-2024-238979.80.79jenkins-agent-04.novacrest.comDevOps21Delayed
CVE-2024-43238.60.53db-analytics-02.novacrest.comData Eng9Testing
CVE Origin Breakdown
Compensating Controls Coverage
Vulnerability Reopen Rate by Asset Class (90 Days)